Home › Merck to Present New Data in Five Tumor Types from Studies Evaluating Pembrolizumab
 

Keywords :   


Merck to Present New Data in Five Tumor Types from Studies Evaluating Pembrolizumab

2014-09-03 05:50:17| Biotech - Topix.net

Merck , known as MSD outside the United States and Canada, today announced the presentation of data from ongoing clinical trials evaluating the anti-tumor activity of pembrolizumab, the company's investigational anti-PD-1 antibody, at the European Society of Medical Oncology 2014 in Madrid, Spain, September 26 - 30. Data on pembrolizumab are ... (more)

Tags: data present types studies

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
30.09UK economy grew less than thought in spring
30.09House price growth at near two-year high
30.09Traditional steelmaking ends in Port Talbot
30.09Eastern North Pacific Tropical Weather Outlook
30.09Atlantic Tropical Weather Outlook
30.09Eastern North Pacific Tropical Weather Outlook
30.09California governor blocks landmark AI safety bill
30.09Tropical Depression Joyce Forecast Advisory Number 11
More »